RE: As18 Jul 2019 19:31
Dnat my view for what it’s worth;
Partner news - late this year. You wouldn’t issue an RNS stating H2 to them do a deal a month or two later, plus it’s clear from the interview the partner wants more efficacy data from what I gather listening carefully. So, H2 sounds about right
Re Clevegen, again, no dates given, but sounded as if nothing imminent given latest data release. Imo we are probably looking 2-3 months here when you look at last data, highly unlikely another batch will be issued so soon
T - god knows as we are lacking detail on next steps and timeline
Sadly imo it’s drifting down on low volume as there isn’t any appetite to “wait around on aim” when people could take a loss, invest elsewhere and come back probably same price or lower
Imo we won’t hear much now until October time but you never know